首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Endoluminal stent-graft placement for repair of abdominal aortic aneurysms in the community setting.
【24h】

Endoluminal stent-graft placement for repair of abdominal aortic aneurysms in the community setting.

机译:腔内支架置入术在社区环境中修复腹主动脉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To demonstrate that results similar to high-volume academic centers can be achieved in the community setting when treating abdominal aortic aneurysm (AAA) using endovascular techniques, given appropriate volume and skill sets. Methods: A retrospective review was conducted of 342 consecutive patients who underwent endovascular aneurysm repair (EVAR) by surgeons in a community hospital group from October 1999 through September 2005. In this population, 245 (71.6%) patients were treated with EVAR and 97 (28.4%) with open surgical repair. Of the 245 EVAR patients (203 men; mean age 73.4+/-9.2 years), 218 AneuRx, 19 Ancure, 6 Excluder, and 2 Zenith stent-grafts were implanted by 2 vascular surgeons to exclude AAAs with a mean diameter of 54+/-11 mm. Patients were followed postoperatively with office visits and computed tomography at 1, 6, and 12 months and annually thereafter. Results: Technical success was achieved in 99.6% (244/245) with 1 intraoperative conversion. Mean operative time was 131+/-57 minutes, with a mean contrast load of 161.6+/-65.5 mL. Thirty-five (14.3%) patients required intraoperative blood transfusion. Length of stay was 2.3+/-4.5 days. Thirty-day mortality was 0.8% (2/245). Secondary procedures were required in 15 (6.1%) patients. Kaplan-Meier estimates of freedom from secondary interventions were 98%, 98%, 95%, and 90% at 12, 24, 36, and 48 months, respectively. At the same time points, freedom from surgical conversion was 99%, 99%, 97%, and 96%, and freedom from aneurysm-related death was 97%, 96%, 96%, and 96%. Conclusion: Endovascular AAA repair provides a less invasive method of managing aortic disease with resultant low perioperative mortality. Results in our community hospital demonstrate that this technology can be applied outside an academic environment in nearly three quarters of the population with excellent short and long-term results.
机译:目的:证明在给定适当的数量和技能的情况下,使用血管内技术治疗腹主动脉瘤(AAA)时,可以在社区环境中获得与大批量学术中心相似的结果。方法:回顾性回顾性分析1999年10月至2005年9月在社区医院接受手术的342例连续接受外科手术的血管内动脉瘤修复(EVAR)的患者。在该人群中,有245例(71.6%)的患者接受了EVAR治疗,其中97例( 28.4%)进行开放式手术修复。在245名EVAR患者(203名男性;平均年龄73.4 +/- 9.2岁)中,由2名血管外科医师植入218例AneuRx,19例Ancure,6例Excluder和2例Zenith支架植入物,以排除平均直径为54+的AAA / -11毫米。术后1、6、12个月以及以后每年对患者进行办公室访问和计算机断层扫描。结果:1次术中转换获得了99.6%(244/245)的技术成功。平均手术时间为131 +/- 57分钟,平均对比负荷为161.6 +/- 65.5 mL。三十五(14.3%)名患者需要术中输血。住院时间为2.3 +/- 4.5天。 30天死亡率为0.8%(2/245)。 15(6.1%)位患者需要进行二次手术。 Kaplan-Meier估计在12、24、36和48个月时,二次干预的自由度分别为98%,98%,95%和90%。在同一时间点,手术转换的自由度为99%,99%,97%和96%,而与动脉瘤相关的死亡的自由度为97%,96%,96%和96%。结论:血管内AAA修复提供了一种治疗主动脉疾病的侵入性较小的方法,从而降低了围手术期死亡率。我们社区医院的结果表明,该技术可以在学术环境之外的近四分之三的人口中得到应用,并具有出色的短期和长期效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号